GlaxoSmithKline PLC Director/PDMR Shareholding (9103W)
April 29 2016 - 12:14PM
UK Regulatory
TIDMGSK
RNS Number : 9103W
GlaxoSmithKline PLC
29 April 2016
GlaxoSmithKline plc
Notification of Transactions of Directors, Persons Discharging
Managerial Responsibilities or Connected Persons
In accordance with DTR 3.1.4R(1)(a) and (c) I give details of
changes in the interests of the following Directors and Persons
Discharging Managerial Responsibilities ('PDMR') who acquired
Ordinary Shares ('Shares') in GlaxoSmithKline plc ('GSK') at a
price of 1496.49 pence per Share, following the re-investment of
the dividend paid to shareholders on 14 April 2016.
Director/PDMR Shares
------------------- ----------
Sir Andrew Witty 2,257.407
------------------- ----------
Mr R Connor 552.391
------------------- ----------
Mr S A Hussain 1,460.067
------------------- ----------
Mr D S Redfern 2,129.312
------------------- ----------
Dr M M Slaoui 4.719
------------------- ----------
Ms C Thomas 2,692.384
------------------- ----------
Mr P C Thomson 1,002.153
------------------- ----------
Dr P J T Vallance 3,827.535
------------------- ----------
Ms E Walmsley 2,705.444
------------------- ----------
Connected Person Shares
--------------------- ---------
Mrs K Thomson
(Connected Person
to Mr P C Thomson) 251.103
--------------------- ---------
GSK was informed of these allocations on 28 April 2016.
V A Whyte
Company Secretary
29 April 2016
This information is provided by RNS
The company news service from the London Stock Exchange
END
DSHQKLFLQZFFBBL
(END) Dow Jones Newswires
April 29, 2016 12:14 ET (16:14 GMT)
Gsk (LSE:GSK)
Historical Stock Chart
From Aug 2024 to Sep 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Sep 2023 to Sep 2024